A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
BACKGROUND:Neoadjuvant chemotherapy (NAC) allows earlier treatment of rectal cancer micro-metastases but is not standard of care. There are currently no biomarkers predicting long-term progression-free survival (PFS) benefit from NAC. PATIENTS AND METHODS:In this single arm phase II trial, patients...
المؤلفون الرئيسيون: | Gollins, S, West, N, Sebag-Montefiore, D, Susnerwala, S, Falk, S, Brown, N, Saunders, M, Quirke, P, Ray, R, Parsons, P, Griffiths, G, Maughan, T, Adams, R, Hurt, C |
---|---|
مؤلفون آخرون: | McIntyre, A |
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Springer Nature
2019
|
مواد مشابهة
-
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
حسب: Mukherjee, S, وآخرون
منشور في: (2017) -
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
حسب: Glynne-Jones, R, وآخرون
منشور في: (2007) -
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
حسب: Sebag-Montefiore, D, وآخرون
منشور في: (2005) -
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
حسب: Glynne-Jones, R, وآخرون
منشور في: (2004) -
Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
حسب: Glynne-Jones, R, وآخرون
منشور في: (2005)